HealthPartners Institute Regions Cancer Care Center

Minneapolis, Minnesota 55440

0 studies enrolling now · 2 studies all time

What they study most

Mesothelioma, Malignant, Uveal Melanoma

Studies at this site

• Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma — Stopped early
• Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma — Stopped early